Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
2022 · Molecular Biomedicine · 111 citations
https://doi.org/10.1186/s43556-022-00071-6
R
Ruoning Yang
First Affiliated Hospital of Xinxiang Medical University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
333
Citations
9
h-index
9
i10-index
Ruoning Yang is an academic researcher from First Affiliated Hospital of Xinxiang Medical University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Global Cancer Incidence and Screening & CAR-T cell therapy research. The author has an h-index of 9, co-authored 15 publications.
Papers by this author
worksSafety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: an update evidence from 14 studies
2021 · BMC Cancer · 30 citations
https://doi.org/10.1186/s12885-021-08363-w
A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis
2023 · BMC Geriatrics · 20 citations
https://doi.org/10.1186/s12877-023-04280-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat